Description: Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
Home Page: www.abattis.com
625 Howe Street
Vancouver,
BC
V6C 2M6
Canada
Phone:
808 650 3007
Officers
| Name | Title |
|---|---|
| Mr. Robert J. Abenante BBA, CA, MPAcc | Pres, CEO & Director |
| Mr. Douglas J. Sorocco LLB | Advisor |
| Mr. Guy P. Dancosse CIRC, CRIA, ICD.D, Q.C. | Advisor |
| Mr. Francesco Paolini | CFO & Director |
| Mr. Patrick Mitchell | COO & Director |
| Mr. Shawn Balaghi | Head of Corp. Devel. |
| Mr. Clayton Chessa | Head of Operations |
| Mr. Jim Carter | Head of Mergers and Acquisitions Advisory |
| Mr. Christopher P. Cherry C.A., C.P.A., CA, CGA, CPA | Corp. Comptroller |
| Ms. Nicole Breitinger | Corp. Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.381 |
| Price-to-Sales TTM: | 1.3255 |
| IPO Date: | 1999-02-11 |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |